Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.42
-0.09 (-1.63%)
At close: Mar 9, 2026, 4:00 PM EDT
5.44
+0.02 (0.37%)
After-hours: Mar 9, 2026, 7:08 PM EDT
Compass Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 30.64 | 43.48 | 24.23 | 34.95 | 144.51 | Upgrade
|
| Short-Term Investments | 178.26 | 83.24 | 128.23 | 151.66 | - | Upgrade
|
| Cash & Short-Term Investments | 208.91 | 126.72 | 152.46 | 186.61 | 144.51 | Upgrade
|
| Cash Growth | 64.85% | -16.88% | -18.30% | 29.13% | 206.98% | Upgrade
|
| Prepaid Expenses | 0.91 | 6.03 | 1.42 | 8.18 | 2.59 | Upgrade
|
| Total Current Assets | 209.82 | 132.75 | 153.88 | 194.79 | 147.11 | Upgrade
|
| Property, Plant & Equipment | 9.2 | 7.08 | 2.67 | 4.53 | 6.33 | Upgrade
|
| Other Long-Term Assets | 0.57 | 0.57 | 0.32 | 0.32 | 0.32 | Upgrade
|
| Total Assets | 219.59 | 140.4 | 156.88 | 199.65 | 153.76 | Upgrade
|
| Accounts Payable | 1.59 | 2.25 | 4.09 | 3.38 | 0.87 | Upgrade
|
| Accrued Expenses | 11.38 | 6.29 | 2.51 | 11.69 | 8.78 | Upgrade
|
| Current Portion of Leases | 1 | 0.34 | 1.2 | 1.1 | 0.99 | Upgrade
|
| Total Current Liabilities | 13.97 | 8.87 | 7.8 | 16.17 | 10.63 | Upgrade
|
| Long-Term Leases | 8.83 | 6.3 | 0.54 | 1.84 | 3.05 | Upgrade
|
| Total Liabilities | 22.8 | 15.17 | 8.34 | 18.01 | 13.68 | Upgrade
|
| Common Stock | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 627.67 | 489.69 | 463.8 | 454.74 | 373.66 | Upgrade
|
| Retained Earnings | -431.17 | -364.68 | -315.31 | -272.81 | -233.59 | Upgrade
|
| Comprehensive Income & Other | 0.28 | 0.21 | 0.04 | -0.3 | - | Upgrade
|
| Total Common Equity | 196.79 | 125.23 | 148.54 | 181.64 | 140.08 | Upgrade
|
| Shareholders' Equity | 196.79 | 125.23 | 148.54 | 181.64 | 140.08 | Upgrade
|
| Total Liabilities & Equity | 219.59 | 140.4 | 156.88 | 199.65 | 153.76 | Upgrade
|
| Total Debt | 9.83 | 6.63 | 1.73 | 2.94 | 4.04 | Upgrade
|
| Net Cash (Debt) | 199.08 | 120.09 | 150.73 | 183.67 | 140.48 | Upgrade
|
| Net Cash Growth | 65.78% | -20.33% | -17.94% | 30.75% | 272.20% | Upgrade
|
| Net Cash Per Share | 1.26 | 0.87 | 1.19 | 1.75 | 2.23 | Upgrade
|
| Filing Date Shares Outstanding | 180.09 | 138.28 | 137.59 | 126.31 | 100.83 | Upgrade
|
| Total Common Shares Outstanding | 178.32 | 137.82 | 127.67 | 126.3 | 100.83 | Upgrade
|
| Working Capital | 195.85 | 123.88 | 146.08 | 178.62 | 136.47 | Upgrade
|
| Book Value Per Share | 1.10 | 0.91 | 1.16 | 1.44 | 1.39 | Upgrade
|
| Tangible Book Value | 196.79 | 125.23 | 148.54 | 181.64 | 140.08 | Upgrade
|
| Tangible Book Value Per Share | 1.10 | 0.91 | 1.16 | 1.44 | 1.39 | Upgrade
|
| Machinery | 4.76 | 4.74 | 5.19 | 5.16 | 5.37 | Upgrade
|
| Leasehold Improvements | 1.61 | 1.61 | 1.61 | 1.61 | 1.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.